Evidence map›Paper›PMID 32908184›Full record

ReviewJournal of public health policy2020

Governing antimicrobial resistance: a narrative review of global governance mechanisms.

Arne Ruckert, Patrick Fafard, Suzanne Hindmarch, Andrew Morris, Corinne Packer, David Patrick, Scott Weese, Kumanan Wilson, Alex Wong, Ronald Labonté

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of public health policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Chimeric hBPIArchives of microbiology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2022
    Article
  17. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arne RuckertCorinne School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON, K1G 3Z7, Canada. aruckert@uottawa.ca.ORCID https://orcid.org/0000-0001-5689-0629
Patrick FafardGraduate School of Public and International Affairs, University of Ottawa, 120 University Private, Ottawa, ON, K1N 6N5, Canada.ORCID https://orcid.org/0000-0001-6234-3699
Suzanne HindmarchDepartment of Political Science, University of New Brunswick, 3 Bailey Drive, Fredericton, NB, E3B 5A3, Canada.
Andrew MorrisFaculty of Medicine, University of Toronto, Medical Sciences Building, 1 King's College Cir, Toronto, ON, M5S 1A8, Canada.
Corinne PackerCorinne School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON, K1G 3Z7, Canada.
David PatrickSchool of Population and Public Health, University of British Columbia, East Mall, Vancouver, BC, V6T 1Z3, Canada.ORCID https://orcid.org/0000-0001-8084-725X
Scott WeeseDepartment of Pathobiology, Ontario Veterinary College, University of Guelph, 50 Stone Road East, Guelph, ON, NIG 2W1, Canada.ORCID https://orcid.org/0000-0003-1896-1937
Kumanan WilsonOttawa Hospital, Civic Campus, 1053 Carling Avenue Administrative Services Building, Box 684, Ottawa, ON, K1Y 4E9, Canada.ORCID https://orcid.org/0000-0002-1741-7705
Alex WongDepartment of Biology, Carleton University, 1125 Colonel By Drive, Ottawa, ON, K1S 5B6, Canada.
Ronald LabontéCorinne School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON, K1G 3Z7, Canada.ORCID https://orcid.org/0000-0002-0615-740X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR), a central health challenge of the twenty first century, poses substantial population health risks, with deaths currently estimated to be around 700,000 per year globally. The international community has signaled its commitment to exploring and implementing effective policy responses to AMR, with a Global Action Plan on AMR approved by the World Health Assembly in 2015. Major governance challenges could thwart collective efforts to address AMR, along with limited knowledge about how to design effective global governance mechanisms. To identify common ground for more coordinated global actions we conducted a narrative review to map dominant ideas and academic debates about AMR governance. We found two categories of global governance mechanisms: binding and non-binding and discuss advantages and drawbacks of each. We suggest that a combination of non-binding and binding governance mechanisms supported by leading antimicrobial use countries and important AMR stakeholders, and informed by One Health principles, may be best suited to tackle AMR.

Indexed as

Anti-Infective AgentsClinical GovernanceDrug Resistance, BacterialAnti-Bacterial AgentsGlobal HealthHumansAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial resistanceGlobal governanceHealth regulationsInternational law

Identifiers

PMID32908184
PMCPMC7479750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.